BioLife Solutions Inc (BLFS)
Quick ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 95,386 | 27,896 | 19,442 | 69,860 | 90,403 |
| Short-term investments | US$ in thousands | 9,198 | 16,893 | 44,658 | 40 | 5,872 |
| Receivables | US$ in thousands | 9,168 | 18,657 | 33,936 | 23,217 | 8,006 |
| Total current liabilities | US$ in thousands | 32,734 | 42,178 | 44,582 | 42,700 | 15,573 |
| Quick ratio | 3.48 | 1.50 | 2.20 | 2.18 | 6.70 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($95,386K
+ $9,198K
+ $9,168K)
÷ $32,734K
= 3.48
The quick ratio of BioLife Solutions Inc has shown a declining trend over the years. It was at a robust level of 6.70 as of December 31, 2020, indicating the company had significant liquid assets to cover its current liabilities in the short term. However, this ratio decreased to 2.18 by December 31, 2021, suggesting a reduction in the company's ability to quickly meet its short-term obligations using its most liquid assets.
Although there was a slight improvement in the quick ratio to 2.20 by December 31, 2022, it remained below the 2020 levels. Furthermore, the ratio decreased further to 1.50 as of December 31, 2023, indicating a concerning decrease in liquidity and the company's ability to cover immediate obligations without relying on the sale of inventory.
The most recent data point available shows an increase in the quick ratio to 3.48 as of December 31, 2024. While this is an improvement from the previous year, the quick ratio still remains below the levels seen in 2020. Overall, the declining trend in BioLife Solutions Inc's quick ratio suggests a potential liquidity challenge, and stakeholders may need to monitor this metric closely to assess the company's ability to meet its short-term financial obligations efficiently.
Peer comparison
Dec 31, 2024